Avanos Medical (AVNS) Change in Receivables (2013 - 2026)
Avanos Medical (AVNS) posted Change in Receivables of $300000.0 for Q1 2026, up 103.7% sequentially from -$8.1 million in Q4 2025, and up 101.2% YoY from $149108.9 in Q1 2025.
Avanos Medical (AVNS) Change in Receivables (2013 - 2026) Analysis & Trends
Avanos Medical has reported Change in Receivables for 14 years, with the latest figure at $300000.0 in Q1 2026.
- Quarterly Change in Receivables rose 101.2% year-over-year to $300000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.5 million (up 46.6% YoY) and the FY2025 annual result came in at -$30.9 million, down 568.18% from the prior year.
- Change in Receivables advanced to $300000.0 in Q1 2026 per AVNS's latest filing, from -$8.1 million in the prior quarter.
- Over five years, Change in Receivables peaked at $18.7 million in Q4 2022 and troughed at -$26.2 million in Q1 2023.
- A 5-year average of -$2.3 million and a median of -$700000.0 in 2025 frame the typical range for Change in Receivables.
- The sharpest annual moves came in 2022 and 2025: Change in Receivables surged 6133.33% in 2022, then sank 2600.0% in 2025.
- Over 5 years, Change in Receivables stood at $18.7 million in 2022, then sank by 148.13% to -$9.0 million in 2023, then soared by 96.67% to -$300000.0 in 2024, then tumbled by 2600.0% to -$8.1 million in 2025, then jumped by 103.7% to $300000.0 in 2026.
- According to Business Quant data, Change in Receivables over the past three periods registered $300000.0, -$8.1 million, and -$700000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 386.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 177.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 46.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 172.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 79.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | -90.00 Mn |
| 10 | Avanos Medical | 1.17 Bn | 1.10 Bn | 94.20 Mn | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | -8.10 Mn |
| Dec 31, 2025 | -8.10 Mn |
| Sep 30, 2025 | -700,000.00 |
| Sep 30, 2025 | -700,000.00 |
| Jun 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | -25.10 Mn |
| Mar 31, 2025 | -25.10 Mn |
| Dec 31, 2024 | -300,000.00 |
| Dec 31, 2024 | -300,000.00 |
| Sep 30, 2024 | 7.70 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Jun 30, 2024 | 7.40 Mn |
| Mar 31, 2024 | -8.20 Mn |
| Mar 31, 2024 | -8.20 Mn |
| Dec 31, 2023 | -9.00 Mn |
| Dec 31, 2023 | -9.00 Mn |